The Malaria Diagnostics Market is anticipated to reach USD 796.4
Million by 2030 at 5.60% CAGR during the forecast period 2022-2030.
Primary and precise
diagnosis of malaria is essential for both fast and effective disease
management and observation. Superior quality malaria diagnosis systems are
important in all settings as misdiagnosis or misinterpretation can result in
substantial morbidity and mortality. World Health Organization (WHO) recommends
a quick malaria diagnosis either by microscopy or malaria rapid diagnostic test
(RDT) in all patients with suspected malaria before treatment is being
administered. Diagnostic testing improves the overall management of patients
with febrile illnesses and may also help to decrease the emergence and spread
of drug resistance by storing antimalarials for those who have the disease. The
scope of malaria diagnostics is growing rapidly with technological advancements
and a growing number of investments. Also, growth in a number of hospitals and
healthcare facilities, and initiatives taken by the government are the major
factors driving the growth of the malaria diagnostics market.
However, the dearth
of appropriate monitoring standards at the country levels particularly in
developing markets hinders the growth of the market. The weak regulatory
framework and lack of awareness across the emerging nations is also a prime
concern for the manufacturers and healthcare providers.
Major Key
Players:
The leveraging of AI and IoT is estimated to gain traction with more
integration of technology in the operations related to production and logistics
in the upcoming period. The creation of a novel working environment is
predicted to influence the market on a global scale further. The market is on
the precipice of changing the course of development in the near future with the
implementation of new strategies. The diversification of risk and assets owned
is estimated to be seen as a major trend in the impending period. Investors'
role in the revitalization of the market's operation and growth is anticipated
to be vital. The increased reliance on e-commerce platforms to push the sales
level is estimated to be another key factor that will drive the development of
the global market in the approaching period. The reinstatement of buyer demand
and fiscal feasibility is appraised to deliver optimistic odds for the
businesses' expansion in the forecast period.
The Malaria Diagnostics Market Players are Premier Medical
Corporation Pvt. Ltd, bioMérieux, Access Bio. Inc., Sysmex Partec GmbH, Siemens
Healthineers, Leica Microsystems GmbH, Nikon Corporation, Olympus Corporation,
Abbott Laboratories, Beckman Coulter Inc., and Bio-Rad Laboratories Inc to name
a few.
Segment Analysis
The global malaria diagnostics market has been
segmented on the basis of technology and end-user.
On the basis of technology, the market has been
classified as rapid diagnostic tests, microscopy, and molecular diagnostic
tests. The molecular diagnostics tests are segmented into polymerase chain
reaction (PCR) and real-time polymerase chain reaction (RT-PCR).
On the basis of end-users, the market has been
classified as hospitals, clinics, community healthcare, and others.
Regional Analysis
The regional examination of the malaria diagnostics market is segmented
into Europe, the Middle East, Asia-Pacific, the Americas, and Africa. The North
American region in the malaria diagnostics market is predicted to account for
the prime market segment due to the initial adoption of progressive medical
technologies, the upsurge in awareness, the intensification in the development
of the healthcare sector, and the promising reimbursement for several surgical
procedures.
The US national was the largest contributor by providing USD 1 billion
for the eradication of malaria. The European national malaria diagnostics
market is anticipated to hold the minimum share due to the region's mounting
amount of malaria-free countries.
The malaria diagnostics market share in the Asia Pacific is also
anticipated to undergo development in the near future owing to admission to
optimal treatment amenities and increasing demand for progressive technology,
healthier adoption rate, upsurge in disposable income, and intensifying medical
tourism. The malaria diagnostics market in the Middle Eastern and African
regions is likely to take the global market's minimum share due to an
underdeveloped healthcare segment, deficiency of technical data, and lowly
medical facilities.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
